AMN Healthcare price target lowered to $75 from $87 at JMP Securities

JMP Securities analyst Constantine Davides lowered the firm’s price target on AMN Healthcare to $75 from $87 and keeps an Outperform rating on the shares. The firm’s model now appropriately contemplates a more conservative stance with respect to near-term secular trends and ensuring that it is aligning more tightly to AMN’s 1H24 commentary, the analyst tells investors in a research note.